FW: [Histonet] FITC on Ventana Ultra

[Kasprowicz, Emily E]

Emily Kasprowicz, HT (ASCP)
Histology Lab
Hennepin County Medical Center
701 Park Avenue
Minneapolis, MN 55415
612-873-3079
________________________________________
From: Kasprowicz, Emily E
Sent: Friday, August 27, 2010 1:13 PM
To: Morken, Tim
Subject: RE: [Histonet] FITC on Ventana Ultra

We have a Benchmark XT and LT, and this has been somewhat of a nuisance, but not as much as the procedure that you have described. We, too, have to trick the system. What we have come up with (however, we have not been inspected by CAP since implementing this, so I don't know if this will be acceptable to the inspector) is to make a "titer" protocol for each of our antibodies. The protocol is exactly the same as our normal run, but we have to manually apply the antibody to the correct slide (we label our test slides with the lot numbers and "Old Lot" and "New Lot") at the time of antibody incubation. This was the least complicated way we could come up with to do the "side by side" testing required by CAP, and it seems to work pretty well. Our problem is is that we have to wait for a time when one of the machines is totally free so we can do the titer run. This is, of course, not very often, so we have to try to do lot comparisons as far in advance as possible.
If we had the Ventana Ultra, it would be a little easier as we wouldn't have to hold up the entire machine for a Titer Run. We could just run the slides as needed.

If anyone else has a better way to do lot checks on the Ventana Benchmarks, I'd be interested in hearing your procedure as well.

Thanks,
Emily Kasprowicz, HT (ASCP)
Histology Lab
Hennepin County Medical Center
701 Park Avenue
Minneapolis, MN 55415
612-873-3079
________________________________________
From: histonet-bounces <@t> lists.utsouthwestern.edu [histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Morken, Tim [Timothy.Morken <@t> ucsfmedctr.org]
Sent: Friday, August 27, 2010 11:52 AM
To: histonet <@t> lists.utsouthwestern.edu
Subject: RE: [Histonet] FITC on Ventana Ultra

Part of the Ventana response was "Many customers, however have expressed that they would rather utilize the slide drawer for another patient slide, rather than running the fitc negative."

I hope the customers come to understand that the negative control is necessary, not just an option.


Also, it has come to light that it is difficult to run lot comparison tests on some automated instruments as CAP is now requiring. From Ventana the information I have gotten is that the customer has to "trick" the system to be able to test two lots in one run. Two lots of the same antibody can be used on one run, but the system will use the oldest lot first, then switch to the new lot when the old lot runs out. So to do a lot comparison the customer must arrange to use the last test from the old lot on one slide and then assume the system will switch to the new lot for the other slide. Hopefully it works.

I don't use Ventana but am interested because we are looking at the system, plus I am giving a validation workshop at NSH and one of the most common questions now is how to do a lot comparison test on an automated system. I welcome any other information on that process on any system.

Tim Morken
Supervisor, Histology, IPOX
UCSF Medical Center
San Francisco, CA, USA

-----Original Message-----
From: histonet-bounces <@t> lists.utsouthwestern.edu [mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Nita Searcy
Sent: Friday, August 27, 2010 7:30 AM
To: histonet <@t> lists.utsouthwestern.edu
Subject: [Histonet] FITC on Ventana Ultra

Any users out there that have had A CAP inspector question negative control on the instrument? In regard to CAP question ANP.21850 in which the notes state, "A negative reagent control in which the patient tissue is processed in an identical manner to the test specimen but with the primary antibody omitted must be performed for each patient test specimen?"

Below is the response from Ventana regarding "negatives" I am curios if CAP accepts these methods??

In regards to the question below about running a negative control fitc, there are two ways to accomplish this.



1) There is not currently a place in the protocol to select a fitc negative. We can still be compliant by ensuring the negative slide is treated the same as the patient. The only reagent the patient slide is exposed to, besides the fitc antibody, is reaction buffer. Running a negative can be accomplished by applying reaction buffer to the slide and letting it incubate for the same amount of time. Next, it is important to ensure both slides are coverslipped in the came mounting media.
2) The second method is to utilize internal negatives that are already present within the patient tissue. However, this is difficult when running Fitc antibodies such as IgG, IgM, etc.
We are looking into adding this addition into the software. Many customers, however have expressed that they would rather utilize the slide drawer for another patient slide, rather than running the fitc negative.

Am interested in your comments.
Thanks





Nita Searcy, HT/HTL (ASCP)
Scott and White Hospital
Division Manager, Anatomic Pathology
2401 S. 31st. Street
254-724-2438
Temple, Texas, 76502
nsearcy <@t> swmail.sw.org


254-724-2438



_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet